News
-
-
-
-
COMMUNIQUÉ DE PRESSE
Terry Lynch Continues as Capital Markets Advisor and BioNxt Retains Investor Relations Professionals
BioNxt Solutions Inc. announces Terry Lynch as capital markets advisor and retention of two investor relations professionals, Rob Grace and Blaine Ruzcki, for promotional activities. Company focuses on bioscience innovations with drug delivery platforms -
-
COMMUNIQUÉ DE PRESSE
Onco-Innovations Commences Activities to Manufacture Nanoparticle Formulation with Dalton Pharma to Supply Preclinical Animal Studies
Onco-Innovations announces manufacturing of nanoparticle formulation by Dalton Pharma Services to advance preclinical studies, enhancing clinical readiness in cancer research -
COMMUNIQUÉ DE PRESSE
RE Royalties Announces Cancellation of Previously Announced Non-Brokered Listed Issuer Financing Equity Offering Due to Early Repayment from Clients
RE Royalties cancels private placement offering due to early loan repayments and share price volatility. Company well-capitalized for new opportunities and meeting bond maturity -
-
COMMUNIQUÉ DE PRESSE
Rapport Financier Semestriel 30 juin 2025
-
COMMUNIQUÉ DE PRESSE
GENFIT annonce l'arrêt de son programme VS-01 dans l'ACLF – le développement de VS-01 est recentré sur l'UCD
GENFIT annonce l'arrêt de son programme VS-01 dans l'ACLF et se recentre sur l'UCD pour traiter les troubles du cycle de l'urée. L'arrêt fait suite à un événement indésirable grave dans l'essai clinique UNVEIL-IT®